Weight Loss with FT218, a Once-Nightly Sodium Oxybate Formulation (ON-SXB), for the Treatment of Narcolepsy: Post Hoc Analysis from REST-ON

被引：0
|
作者：
Morse, Anne Marie [1 ]
Roy, Asim [2 ]
Dubow, Jordan [3 ]
Seiden, David [3 ]
Bogan, Richard [4 ,5 ]
机构：
[1] Janet Weis Childrens Hosp, Geisinger Med Ctr, Geisinger Commonwealth Sch Med, Danville, PA USA
[2] Ohio Sleep Med Inst, Dublin, OH USA
[3] Avadel Pharmaceut, Chesterfield, MO USA
[4] Univ South Carolina, Sch Med, Charleston, SC USA
[5] Med Univ SC, Charleston, SC USA
来源：
ANNALS OF NEUROLOGY | 2021年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
286
引用
收藏
页码：S242 / S242
页数：1
相关论文
共 50 条
  • [31] Efficacy of once-nightly sodium oxybate (FT218) on daytime symptoms in individuals with narcolepsy with or without concomitant alerting agent use: A post hoc analysis from the phase 3 REST-ON trial
    Dauvilliers, Yves
    Roth, Thomas
    Bogan, Richard
    Thorpy, Michael J.
    Morse, Anne Marie
    Roy, Asim
    Gudeman, Jennifer
    SLEEP MEDICINE, 2024, 124 : 209 - 216
  • [32] SLEEP LATENCY RESPONSE WITH FT218, A ONCE-NIGHTLY SODIUM OXYBATE: POST-HOC RESPONDER ANALYSES FROM THE PHASE 3 REST-ON CLINICAL TRIAL
    Winkelman, John
    Ohayon, Maurice
    Thorpy, Michael
    Seiden, David
    Bogan, Richard
    Dubow, Jordan
    Shapiro, Colin
    CHEST, 2021, 160 (04) : 2426A - 2428A
  • [33] Polysomnographic Measures of Sleep Continuity in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation
    Dauvilliers, Yves
    Thorpy, Michael
    Roth, Thomas
    Rosenberg, Russell
    Corser, Bruce
    Shapiro, Colin
    Ajayi, Akinyemi
    Dubow, Jordan
    Seiden, David
    Kushida, Clete
    NEUROLOGY, 2021, 96 (15)
  • [34] THE PHARMACOKINETIC ADVERSE EVENT RELATIONSHIP FOR FT218, A ONCE-NIGHTLY SODIUM OXYBATE FORMULATION
    Seiden, D.
    Grassot, J.
    Monteith, D.
    Dubow, J.
    SLEEP, 2020, 43 : A282 - A283
  • [35] CHARACTERIZATION OF PATIENTS WHO HAD ≥5% WEIGHT LOSS WITH ONCE-NIGHTLY SODIUM OXYBATE: POST HOC ANALYSIS FROM REST-ON
    Roth, T.
    Morse, A. M.
    Bogan, R.
    Roy, A.
    Dubow, J.
    Gudeman, J.
    Dauvilliers, Y.
    SLEEP MEDICINE, 2024, 115 : 209 - 209
  • [36] The Pharmacokinetic-Adverse Event Relationship For FT218, a Once-Nightly Sodium Oxybate Formulation
    Seiden, David
    Grassot, Julien
    Monteith, David
    Dubow, Jordan
    NEUROLOGY, 2020, 94 (15)
  • [37] Adis Summary of Research: Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial
    Julia Paik
    Drugs & Therapy Perspectives, 2023, 39 : 165 - 166
  • [38] Adis Summary of Research: Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial
    Paik, Julia
    DRUGS & THERAPY PERSPECTIVES, 2023, 39 (05) : 165 - 166
  • [39] Daytime Sleepiness, Sleep Quality, Hallucinations, and Sleep Paralysis in Patients With Narcolepsy: Results From the REST-ON Trial, a Pivotal Phase 3 Study of FT218, a Once-Nightly Sodium Oxybate Formulation
    Thorpy, Michael
    Roth, Thomas
    Dauvilliers, Yves
    Kushida, Clete
    Shapiro, Colin
    Corser, Bruce
    Ajayi, Akinyemi
    Dubow, Jordan
    Seiden, David
    Rosenberg, Russell
    NEUROLOGY, 2021, 96 (15)
  • [40] Once-nightly sodium oxybate (FT218) improved symptoms in people with narcolepsy: a plain language summary of publication
    Kushida, Clete A.
    Thorpy, Michael J.
    Flygare, Julie
    Roy, Asim
    Dubow, Jordan
    Seiden, David
    FUTURE NEUROLOGY, 2022, 17 (05)
12345